aluates Reports

$ 0.0

Automative

Global GLP-1-based Therapy Market Research Report 2024

Published Date: August 2024

Report Code: QYRE-Auto-29S17635

BUY CHAPTERS

Global GLP-1-based Therapy Market Research Report 2024

Code: QYRE-Auto-29S17635

Report

August 2024

Pages:85

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Novo Nordisk

Eli Lilly

Astrazeneca plc

Sanofi

GSK

Hanson

Shanghai Renhui Biopharmaceutical

Huadong Medicine

Sino Biopharm

GLP-1-based Therapy Market

GLP-1-based therapy involves the use of medications that mimic the actions of glucagon-like peptide-1(GLP-1).They work by stimulating insulin secretion in response to elevated blood sugar levels,inhibiting glucagon release,delaying gastric emptying,and promoting a feeling of fullness.These effects help to lower blood glucose levels,improve glycemic control,and often result in weight loss,which are primarily used to manage type 2 diabetes mellitus and loss weight.

The global GLP-1-based Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

North American market for GLP-1-based Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for GLP-1-based Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of GLP-1-based Therapy include Novo Nordisk, Eli Lilly, AstraZeneca, Sanofi, GSK, Hanson, Shanghai Renhui Biopharmaceutical, Huadong Medicine, Sino Biopharm, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for GLP-1-based Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GLP-1-based Therapy.

The GLP-1-based Therapy market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global GLP-1-based Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the GLP-1-based Therapy manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of GLP-1-based Therapy Market Report

Report Metric	Details
Report Name	GLP-1-based Therapy Market
Segment by Type	Injection Tablets Other
Segment by Application	Type 2 Diabetes Obesity
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Novo Nordisk, Eli Lilly, AstraZeneca, Sanofi, GSK, Hanson, Shanghai Renhui Biopharmaceutical, Huadong Medicine, Sino Biopharm
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of GLP-1-based Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of GLP-1-based Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the GLP-1-based Therapy Market report?

Ans: The main players in the GLP-1-based Therapy Market are Novo Nordisk, Eli Lilly, AstraZeneca, Sanofi, GSK, Hanson, Shanghai Renhui Biopharmaceutical, Huadong Medicine, Sino Biopharm

What are the Application segmentation covered in the GLP-1-based Therapy Market report?

Ans: The Applications covered in the GLP-1-based Therapy Market report are Type 2 Diabetes, Obesity

What are the Type segmentation covered in the GLP-1-based Therapy Market report?

Ans: The Types covered in the GLP-1-based Therapy Market report are Injection, Tablets, Other

Recommended Reports

GLP-1 Therapies

Diabetes Management

Obesity Treatments

1 GLP-1-based Therapy Market Overview

1.1 Product Definition

1.2 GLP-1-based Therapy by Type

1.2.1 Global GLP-1-based Therapy Market Value Comparison by Type (2024-2030)

1.2.2 Injection

1.2.3 Tablets

1.2.4 Other

1.3 GLP-1-based Therapy by Application

1.3.1 Global GLP-1-based Therapy Market Value by Application (2024-2030)

1.3.2 Type 2 Diabetes

1.3.3 Obesity

1.4 Global GLP-1-based Therapy Market Size Estimates and Forecasts

1.4.1 Global GLP-1-based Therapy Revenue 2019-2030

1.4.2 Global GLP-1-based Therapy Sales 2019-2030

1.4.3 Global GLP-1-based Therapy Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 GLP-1-based Therapy Market Competition by Manufacturers

2.1 Global GLP-1-based Therapy Sales Market Share by Manufacturers (2019-2024)

2.2 Global GLP-1-based Therapy Revenue Market Share by Manufacturers (2019-2024)

2.3 Global GLP-1-based Therapy Average Price by Manufacturers (2019-2024)

2.4 Global Key Players of GLP-1-based Therapy, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of GLP-1-based Therapy, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of GLP-1-based Therapy, Product Type & Application

2.7 Global Key Manufacturers of GLP-1-based Therapy, Date of Enter into This Industry

2.8 Global GLP-1-based Therapy Market Competitive Situation and Trends

2.8.1 Global GLP-1-based Therapy Market Concentration Rate

2.8.2 The Global 5 and 10 Largest GLP-1-based Therapy Players Market Share by Revenue

2.8.3 Global GLP-1-based Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global GLP-1-based Therapy Market Scenario by Region

3.1 Global GLP-1-based Therapy Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global GLP-1-based Therapy Sales by Region: 2019-2030

3.2.1 Global GLP-1-based Therapy Sales by Region: 2019-2024

3.2.2 Global GLP-1-based Therapy Sales by Region: 2025-2030

3.3 Global GLP-1-based Therapy Revenue by Region: 2019-2030

3.3.1 Global GLP-1-based Therapy Revenue by Region: 2019-2024

3.3.2 Global GLP-1-based Therapy Revenue by Region: 2025-2030

3.4 North America GLP-1-based Therapy Market Facts & Figures by Country

3.4.1 North America GLP-1-based Therapy Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America GLP-1-based Therapy Sales by Country (2019-2030)

3.4.3 North America GLP-1-based Therapy Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe GLP-1-based Therapy Market Facts & Figures by Country

3.5.1 Europe GLP-1-based Therapy Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe GLP-1-based Therapy Sales by Country (2019-2030)

3.5.3 Europe GLP-1-based Therapy Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific GLP-1-based Therapy Market Facts & Figures by Region

3.6.1 Asia Pacific GLP-1-based Therapy Market Size by Region: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific GLP-1-based Therapy Sales by Region (2019-2030)

3.6.3 Asia Pacific GLP-1-based Therapy Revenue by Region (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America GLP-1-based Therapy Market Facts & Figures by Country

3.7.1 Latin America GLP-1-based Therapy Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America GLP-1-based Therapy Sales by Country (2019-2030)

3.7.3 Latin America GLP-1-based Therapy Revenue by Country

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa GLP-1-based Therapy Market Facts & Figures by Country

3.8.1 Middle East and Africa GLP-1-based Therapy Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa GLP-1-based Therapy Sales by Country (2019-2030)

3.8.3 Middle East and Africa GLP-1-based Therapy Revenue by Country

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global GLP-1-based Therapy Sales by Type (2019-2030)

4.1.1 Global GLP-1-based Therapy Sales by Type (2019-2024)

4.1.2 Global GLP-1-based Therapy Sales by Type (2025-2030)

4.1.3 Global GLP-1-based Therapy Sales Market Share by Type (2019-2030)

4.2 Global GLP-1-based Therapy Revenue by Type (2019-2030)

4.2.1 Global GLP-1-based Therapy Revenue by Type (2019-2024)

4.2.2 Global GLP-1-based Therapy Revenue by Type (2025-2030)

4.2.3 Global GLP-1-based Therapy Revenue Market Share by Type (2019-2030)

4.3 Global GLP-1-based Therapy Price by Type (2019-2030)

5 Segment by Application

5.1 Global GLP-1-based Therapy Sales by Application (2019-2030)

5.1.1 Global GLP-1-based Therapy Sales by Application (2019-2024)

5.1.2 Global GLP-1-based Therapy Sales by Application (2025-2030)

5.1.3 Global GLP-1-based Therapy Sales Market Share by Application (2019-2030)

5.2 Global GLP-1-based Therapy Revenue by Application (2019-2030)

5.2.1 Global GLP-1-based Therapy Revenue by Application (2019-2024)

5.2.2 Global GLP-1-based Therapy Revenue by Application (2025-2030)

5.2.3 Global GLP-1-based Therapy Revenue Market Share by Application (2019-2030)

5.3 Global GLP-1-based Therapy Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Novo Nordisk

6.1.1 Novo Nordisk Company Information

6.1.2 Novo Nordisk Description and Business Overview

6.1.3 Novo Nordisk GLP-1-based Therapy Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Novo Nordisk GLP-1-based Therapy Product Portfolio

6.1.5 Novo Nordisk Recent Developments/Updates

6.2 Eli Lilly

6.2.1 Eli Lilly Company Information

6.2.2 Eli Lilly Description and Business Overview

6.2.3 Eli Lilly GLP-1-based Therapy Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Eli Lilly GLP-1-based Therapy Product Portfolio

6.2.5 Eli Lilly Recent Developments/Updates

6.3 AstraZeneca

6.3.1 AstraZeneca Company Information

6.3.2 AstraZeneca Description and Business Overview

6.3.3 AstraZeneca GLP-1-based Therapy Sales, Revenue and Gross Margin (2019-2024)

6.3.4 AstraZeneca GLP-1-based Therapy Product Portfolio

6.3.5 AstraZeneca Recent Developments/Updates

6.4 Sanofi

6.4.1 Sanofi Company Information

6.4.2 Sanofi Description and Business Overview

6.4.3 Sanofi GLP-1-based Therapy Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Sanofi GLP-1-based Therapy Product Portfolio

6.4.5 Sanofi Recent Developments/Updates

6.5 GSK

6.5.1 GSK Company Information

6.5.2 GSK Description and Business Overview

6.5.3 GSK GLP-1-based Therapy Sales, Revenue and Gross Margin (2019-2024)

6.5.4 GSK GLP-1-based Therapy Product Portfolio

6.5.5 GSK Recent Developments/Updates

6.6 Hanson

6.6.1 Hanson Company Information

6.6.2 Hanson Description and Business Overview

6.6.3 Hanson GLP-1-based Therapy Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Hanson GLP-1-based Therapy Product Portfolio

6.6.5 Hanson Recent Developments/Updates

6.7 Shanghai Renhui Biopharmaceutical

6.7.1 Shanghai Renhui Biopharmaceutical Company Information

6.7.2 Shanghai Renhui Biopharmaceutical Description and Business Overview

6.7.3 Shanghai Renhui Biopharmaceutical GLP-1-based Therapy Sales, Revenue and Gross Margin (2019-2024)

6.7.4 Shanghai Renhui Biopharmaceutical GLP-1-based Therapy Product Portfolio

6.7.5 Shanghai Renhui Biopharmaceutical Recent Developments/Updates

6.8 Huadong Medicine

6.8.1 Huadong Medicine Company Information

6.8.2 Huadong Medicine Description and Business Overview

6.8.3 Huadong Medicine GLP-1-based Therapy Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Huadong Medicine GLP-1-based Therapy Product Portfolio

6.8.5 Huadong Medicine Recent Developments/Updates

6.9 Sino Biopharm

6.9.1 Sino Biopharm Company Information

6.9.2 Sino Biopharm Description and Business Overview

6.9.3 Sino Biopharm GLP-1-based Therapy Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Sino Biopharm GLP-1-based Therapy Product Portfolio

6.9.5 Sino Biopharm Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 GLP-1-based Therapy Industry Chain Analysis

7.2 GLP-1-based Therapy Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 GLP-1-based Therapy Production Mode & Process

7.4 GLP-1-based Therapy Sales and Marketing

7.4.1 GLP-1-based Therapy Sales Channels

7.4.2 GLP-1-based Therapy Distributors

7.5 GLP-1-based Therapy Customers

8 GLP-1-based Therapy Market Dynamics

8.1 GLP-1-based Therapy Industry Trends

8.2 GLP-1-based Therapy Market Drivers

8.3 GLP-1-based Therapy Market Challenges

8.4 GLP-1-based Therapy Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Novo Nordisk

Eli Lilly

Astrazeneca plc

Sanofi

GSK

Hanson

Shanghai Renhui Biopharmaceutical

Huadong Medicine

Sino Biopharm

List of Tables

Table 1. Global GLP-1-based Therapy Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global GLP-1-based Therapy Market Value by Application (2024-2030) & (US$ Million)

Table 3. Global GLP-1-based Therapy Market Competitive Situation by Manufacturers in 2023

Table 4. Global GLP-1-based Therapy Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global GLP-1-based Therapy Sales Market Share by Manufacturers (2019-2024)

Table 6. Global GLP-1-based Therapy Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global GLP-1-based Therapy Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market GLP-1-based Therapy Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of GLP-1-based Therapy, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of GLP-1-based Therapy, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of GLP-1-based Therapy, Product Type & Application

Table 12. Global Key Manufacturers of GLP-1-based Therapy, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global GLP-1-based Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GLP-1-based Therapy as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global GLP-1-based Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global GLP-1-based Therapy Sales by Region (2019-2024) & (K Units)

Table 18. Global GLP-1-based Therapy Sales Market Share by Region (2019-2024)

Table 19. Global GLP-1-based Therapy Sales by Region (2025-2030) & (K Units)

Table 20. Global GLP-1-based Therapy Sales Market Share by Region (2025-2030)

Table 21. Global GLP-1-based Therapy Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global GLP-1-based Therapy Revenue Market Share by Region (2019-2024)

Table 23. Global GLP-1-based Therapy Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global GLP-1-based Therapy Revenue Market Share by Region (2025-2030)

Table 25. North America GLP-1-based Therapy Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America GLP-1-based Therapy Sales by Country (2019-2024) & (K Units)

Table 27. North America GLP-1-based Therapy Sales by Country (2025-2030) & (K Units)

Table 28. North America GLP-1-based Therapy Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America GLP-1-based Therapy Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe GLP-1-based Therapy Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe GLP-1-based Therapy Sales by Country (2019-2024) & (K Units)

Table 32. Europe GLP-1-based Therapy Sales by Country (2025-2030) & (K Units)

Table 33. Europe GLP-1-based Therapy Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe GLP-1-based Therapy Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific GLP-1-based Therapy Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific GLP-1-based Therapy Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific GLP-1-based Therapy Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific GLP-1-based Therapy Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific GLP-1-based Therapy Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America GLP-1-based Therapy Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America GLP-1-based Therapy Sales by Country (2019-2024) & (K Units)

Table 42. Latin America GLP-1-based Therapy Sales by Country (2025-2030) & (K Units)

Table 43. Latin America GLP-1-based Therapy Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America GLP-1-based Therapy Revenue Market Share by Country (2019-2024)

Table 45. Middle East and Africa GLP-1-based Therapy Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East and Africa GLP-1-based Therapy Sales by Country (2019-2024) & (K Units)

Table 47. Middle East and Africa GLP-1-based Therapy Sales by Country (2025-2030) & (K Units)

Table 48. Middle East and Africa GLP-1-based Therapy Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East and Africa GLP-1-based Therapy Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global GLP-1-based Therapy Sales (K Units) by Type (2019-2024)

Table 51. Global GLP-1-based Therapy Sales (K Units) by Type (2025-2030)

Table 52. Global GLP-1-based Therapy Sales Market Share by Type (2019-2024)

Table 53. Global GLP-1-based Therapy Sales Market Share by Type (2025-2030)

Table 54. Global GLP-1-based Therapy Revenue (US$ Million) by Type (2019-2024)

Table 55. Global GLP-1-based Therapy Revenue (US$ Million) by Type (2025-2030)

Table 56. Global GLP-1-based Therapy Revenue Market Share by Type (2019-2024)

Table 57. Global GLP-1-based Therapy Revenue Market Share by Type (2025-2030)

Table 58. Global GLP-1-based Therapy Price (US$/Unit) by Type (2019-2024)

Table 59. Global GLP-1-based Therapy Price (US$/Unit) by Type (2025-2030)

Table 60. Global GLP-1-based Therapy Sales (K Units) by Application (2019-2024)

Table 61. Global GLP-1-based Therapy Sales (K Units) by Application (2025-2030)

Table 62. Global GLP-1-based Therapy Sales Market Share by Application (2019-2024)

Table 63. Global GLP-1-based Therapy Sales Market Share by Application (2025-2030)

Table 64. Global GLP-1-based Therapy Revenue (US$ Million) by Application (2019-2024)

Table 65. Global GLP-1-based Therapy Revenue (US$ Million) by Application (2025-2030)

Table 66. Global GLP-1-based Therapy Revenue Market Share by Application (2019-2024)

Table 67. Global GLP-1-based Therapy Revenue Market Share by Application (2025-2030)

Table 68. Global GLP-1-based Therapy Price (US$/Unit) by Application (2019-2024)

Table 69. Global GLP-1-based Therapy Price (US$/Unit) by Application (2025-2030)

Table 70. Novo Nordisk Company Information

Table 71. Novo Nordisk Description and Business Overview

Table 72. Novo Nordisk GLP-1-based Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Novo Nordisk GLP-1-based Therapy Product

Table 74. Novo Nordisk Recent Developments/Updates

Table 75. Eli Lilly Company Information

Table 76. Eli Lilly Description and Business Overview

Table 77. Eli Lilly GLP-1-based Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Eli Lilly GLP-1-based Therapy Product

Table 79. Eli Lilly Recent Developments/Updates

Table 80. AstraZeneca Company Information

Table 81. AstraZeneca Description and Business Overview

Table 82. AstraZeneca GLP-1-based Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. AstraZeneca GLP-1-based Therapy Product

Table 84. AstraZeneca Recent Developments/Updates

Table 85. Sanofi Company Information

Table 86. Sanofi Description and Business Overview

Table 87. Sanofi GLP-1-based Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Sanofi GLP-1-based Therapy Product

Table 89. Sanofi Recent Developments/Updates

Table 90. GSK Company Information

Table 91. GSK Description and Business Overview

Table 92. GSK GLP-1-based Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. GSK GLP-1-based Therapy Product

Table 94. GSK Recent Developments/Updates

Table 95. Hanson Company Information

Table 96. Hanson Description and Business Overview

Table 97. Hanson GLP-1-based Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Hanson GLP-1-based Therapy Product

Table 99. Hanson Recent Developments/Updates

Table 100. Shanghai Renhui Biopharmaceutical Company Information

Table 101. Shanghai Renhui Biopharmaceutical Description and Business Overview

Table 102. Shanghai Renhui Biopharmaceutical GLP-1-based Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Shanghai Renhui Biopharmaceutical GLP-1-based Therapy Product

Table 104. Shanghai Renhui Biopharmaceutical Recent Developments/Updates

Table 105. Huadong Medicine Company Information

Table 106. Huadong Medicine Description and Business Overview

Table 107. Huadong Medicine GLP-1-based Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Huadong Medicine GLP-1-based Therapy Product

Table 109. Huadong Medicine Recent Developments/Updates

Table 110. Sino Biopharm Company Information

Table 111. Sino Biopharm Description and Business Overview

Table 112. Sino Biopharm GLP-1-based Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Sino Biopharm GLP-1-based Therapy Product

Table 114. Sino Biopharm Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. GLP-1-based Therapy Distributors List

Table 118. GLP-1-based Therapy Customers List

Table 119. GLP-1-based Therapy Market Trends

Table 120. GLP-1-based Therapy Market Drivers

Table 121. GLP-1-based Therapy Market Challenges

Table 122. GLP-1-based Therapy Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. Product Picture of GLP-1-based Therapy

Figure 2. Global GLP-1-based Therapy Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global GLP-1-based Therapy Market Share by Type: 2023 & 2030

Figure 4. Injection Product Picture

Figure 5. Tablets Product Picture

Figure 6. Other Product Picture

Figure 7. Global GLP-1-based Therapy Market Value by Application (2024-2030) & (US$ Million)

Figure 8. Global GLP-1-based Therapy Market Share by Application: 2023 & 2030

Figure 9. Type 2 Diabetes

Figure 10. Obesity

Figure 11. Global GLP-1-based Therapy Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global GLP-1-based Therapy Market Size (2019-2030) & (US$ Million)

Figure 13. Global GLP-1-based Therapy Sales (2019-2030) & (K Units)

Figure 14. Global GLP-1-based Therapy Average Price (US$/Unit) & (2019-2030)

Figure 15. GLP-1-based Therapy Report Years Considered

Figure 16. GLP-1-based Therapy Sales Share by Manufacturers in 2023

Figure 17. Global GLP-1-based Therapy Revenue Share by Manufacturers in 2023

Figure 18. Global 5 and 10 Largest GLP-1-based Therapy Players: Market Share by Revenue in GLP-1-based Therapy in 2023

Figure 19. GLP-1-based Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 20. Global GLP-1-based Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 21. North America GLP-1-based Therapy Sales Market Share by Country (2019-2030)

Figure 22. North America GLP-1-based Therapy Revenue Market Share by Country (2019-2030)

Figure 23. United States GLP-1-based Therapy Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Canada GLP-1-based Therapy Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Europe GLP-1-based Therapy Sales Market Share by Country (2019-2030)

Figure 26. Europe GLP-1-based Therapy Revenue Market Share by Country (2019-2030)

Figure 27. Germany GLP-1-based Therapy Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. France GLP-1-based Therapy Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. U.K. GLP-1-based Therapy Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Italy GLP-1-based Therapy Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Russia GLP-1-based Therapy Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Asia Pacific GLP-1-based Therapy Sales Market Share by Region (2019-2030)

Figure 33. Asia Pacific GLP-1-based Therapy Revenue Market Share by Region (2019-2030)

Figure 34. China GLP-1-based Therapy Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Japan GLP-1-based Therapy Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. South Korea GLP-1-based Therapy Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. India GLP-1-based Therapy Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Australia GLP-1-based Therapy Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. China Taiwan GLP-1-based Therapy Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Southeast Asia GLP-1-based Therapy Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Latin America GLP-1-based Therapy Sales Market Share by Country (2019-2030)

Figure 42. Mexico GLP-1-based Therapy Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Brazil GLP-1-based Therapy Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Argentina GLP-1-based Therapy Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Colombia GLP-1-based Therapy Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Middle East and Africa GLP-1-based Therapy Sales Market Share by Country (2019-2030)

Figure 47. Middle East and Africa GLP-1-based Therapy Revenue Market Share by Country (2019-2030)

Figure 48. Turkey GLP-1-based Therapy Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Saudi Arabia GLP-1-based Therapy Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. UAE GLP-1-based Therapy Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Global Sales Market Share of GLP-1-based Therapy by Type (2019-2030)

Figure 52. Global Revenue Market Share of GLP-1-based Therapy by Type (2019-2030)

Figure 53. Global GLP-1-based Therapy Price (US$/Unit) by Type (2019-2030)

Figure 54. Global Sales Market Share of GLP-1-based Therapy by Application (2019-2030)

Figure 55. Global Revenue Market Share of GLP-1-based Therapy by Application (2019-2030)

Figure 56. Global GLP-1-based Therapy Price (US$/Unit) by Application (2019-2030)

Figure 57. GLP-1-based Therapy Value Chain

Figure 58. GLP-1-based Therapy Production Process

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global GLP 1 Weight Loss Drug Market Research Report 2024

GLP 1 Analogues Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global GLP 1 Injection Market Research Report 2024

Global Glucagon like peptide 1 GLP 1 based Therapies Market Research Report 2025

Global GLP 1 Agonists for Obesity Market Research Report 2024

Global Oral GLP 1 Agonist Market Research Report 2024

Global GLP 1 Drug Peptide API Market Research Report 2024

Global GLP 1 Receptor Agonist Drugs Market Research Report 2024

Global GLP 1 Weight Loss Injection Market Research Report 2024

Global GLP 1 Weight Loss Pill Market Research Report 2024

Global GLP 1 Agonist Injection Market Research Report 2024

Global GLP 1 Drugs Market Research Report 2024

Global GLP 1RA based Therapy for Obesity Market Research Report 2024

GLP 1 for Diabetes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global GLP 1RA Therapy Market Research Report 2024

Global Glucagon Like Peptide 1 GLP 1 Agonists Market Research Report 2025

Global Antidiabetic Glucagon like Peptide 1 Agonists Market Research Report 2025

Global GLP 1 Receptor Antagonist Market Research Report 2024

Global GLP 1 Agonists for the Treatment of both Diabetes and Obesity Market Research Report 2024

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Chronic Pain Medical Devices Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-0I20198

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Disposable Insulin Pen Needle Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-33W11115

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32E19705

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions